2Parvanova A I, Trevisan R, Iliev I P, et al. Insulin resistance and microalbuminuria: across-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion[J]. Diabetes, 2006, 55: 1456-1462.
3Shostak A, Wajsbrot V, Gotlolb L, et al. Protective effect to aminoguanidine upon capillary and submesothelial anionic sites[J].Microvasc Res, 2001, 61 : 166-178.
4Sawanvawisuth K, Linpawattana P, Mahankkanukrauh A, et al. The rate of checking urine microalbumin and aspirin primary prevention in type 2 DM[J]. J Med Assoc Thai, 2006, 89 (5): 626-631.
5Weir M R. Microalbuminuria in type 2 diabetics: an important, overlooked cardiovascular risk factor [ J ]. J Clin Hypertens(Greenwich), 2004, 6 (3): 134-141.
6J. S. Yudkin,A. Panahloo,C. Stehouwer,J. J. Emeis,K. Bulmer,V. Mohamed-Ali,A. E. Denver. The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II Diabetic subjects[J] 2000,Diabetologia(9):1099～1106
7C. G. Schalkwijk,D. C. W. Poland,W. van Dijk,A. Kok,J. J. Emeis,A. M. Dr?ger,A. Doni,V. W. M. van Hinsbergh,C. D. A. Stehouwer. Plasma concentration of C-reactive protein is increased in Type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation[J] 1999,Diabetologia(3):351～357
8J. C. Pickup,M. A. Crook. Is Type II diabetes mellitus a disease of the innate immune system?[J] 1998,Diabetologia(10):1241～1248
9J. C. Pickup,M. B. Mattock,G. D. Chusney,D. Burt. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X[J] 1997,Diabetologia(11):1286～1292
